How much does a box of Fruquintinib cost?

Fruquintinib (Fruquintinib) is a new oral targeted drug mainly used to treat patients with advanced gastric cancer or colorectal cancer, especially those whose disease has progressed after previous treatment with standard chemotherapy and trastuzumab.

Fruquintinib is a drug developed in Hong Kong, China. It has been approved for marketing by the State Food and Drug Administration and has been included in medical insurance. Patients can buy it in domestic hospital pharmacies at a price of about one to two thousand. For specific prices, please consult the local hospital pharmacy.

The main indication for fruquintinib is the treatment of advanced gastric cancer or colorectal cancer. This means it is typically considered for patients whose tumors have spread to surrounding tissue or other sites and who have had limited response to traditional treatment options.

As a multi-target small molecule kinase inhibitor, fruquintinib mainly inhibits multiple targets, including vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR). This mechanism of action allows it to block the tumor's blood supply and slow its growth and spread.

The recommended dosage is oral administration, 1 time daily, 5 mg each time. The treatment cycle is 4 weeks, followed by 1 week of discontinuation, which constitutes a complete treatment cycle. Patients need to closely follow their doctor's advice while taking the medication and receive regular checkups to monitor the efficacy and side effects of the treatment.

The side effects of fruquintinib include but are not limited to fatigue, loss of appetite, hypertension, hand-foot syndrome, gastrointestinal reactions, etc. These side effects may have a certain impact on the patient's quality of life, so patients should pay close attention to their condition during medication and communicate with their doctor in a timely manner in order to adjust the treatment plan.